It appears there in no desire at this time to advertise to retail investors and only focus on the science, licenses, acquisitions and institutional investors. If that wasn't the case, given the experience and connections Deanne Eagle has, you would have seen stories about the company in the public eye even if it was on only secondary media venues. Maybe they held off because of the holidays and will start now, or just continue to focus on the uplist and spinout. No one here knows.

It also appears the torsion spring continues to get wound tighter and tighter as they hit milestones and add additional surprises along the way (ESS, MSPresise, GT Exosomes, etc.). We are only two weeks into the year and the company is off to a great start.

Coverage today on CNN or other media outlets would cause the sp to spike significantly, but subsequently fall rapidly due to short-term traders.

Institutional investors jumping in after the uplist, buying and holding big blocks would be preferable to folks holding long-term. Short-term traders will do well also if they can get in.

I am fine with the spring getting wound as tight as it can go before they let if fly. You never know if the spring is only good for one shot. While this can be frustrating to many, I'd rather make one trade when the sp get to $8 for a 100x gain than have to grind it out with 10,000 trades 10% at a time which requires too much time and stress. Hopefully everyone that has the patience and ethics walks away with 100x gain, regardless of the way you get there.